Caspase-3 activity is reduced after spinal cord injury in mice lacking dynorphin: Differential effects on glia and neurons

Bakshi, 1992, N-methyl-D-aspartate (NMDA) and opioid receptors mediate dynorphin-induced spinal cord injury: behavioral and histological studies, Brain Res, 580, 10.1016/0006-8993(92)90952-6 Beattie, 2002, ProNGF induces p75-mediated death of oligodendrocytes following spinal cord injury, Neuron, 36, 375, 10.1016/S0896-6273(02)01005-X Behrmann, 1993, A comparison of YM-14673, U-50488H and Nalmefene after spinal cord injury in the rat, Exp Neurol, 119, 258, 10.1006/exnr.1993.1028 Benjamins, 2003, Protection of mature oligodendrocytes by inhibitors of caspases and calpains, Neurochem Res, 28, 143, 10.1023/A:1021612615554 Berman, 1994, Regional distribution of neuropeptide processing endopeptidases in adult rat brain, Biochimie, 76, 245, 10.1016/0300-9084(94)90153-8 Campbell, 2003, Apoptotic pathway and MAPKs differentially regulate chemotropic responses of retinal growth cones, Neuron, 37, 939, 10.1016/S0896-6273(03)00158-2 Caudle, 2000, Dynorphin: friend or foe?, Pain, 87, 235, 10.1016/S0304-3959(00)00360-2 Chen, 1995, The opioid peptide dynorphin directly blocks NMDA receptor channels in the rat, J Physiol, 482, 575, 10.1113/jphysiol.1995.sp020541 Chou, 1996, Differential biotransformation of dynorphin A(1-17) and dynorphin A (1-13) peptides in human blood, ex vivo, Peptides, 17, 983, 10.1016/0196-9781(96)00154-4 Christensson-Nylander, 1985, A general procedure for analysis of proenkephalin B derived opioid peptides, Regul Pept, 11, 65, 10.1016/0167-0115(85)90032-1 Christensson-Nylander, 1985, Dynorphin peptides in human substantia nigra, Neuropeptides, 6, 391, 10.1016/0143-4179(85)90137-4 Citron, 2000, Rapid upregulation of caspase-3 in rat spinal cord after injury: mRNA, protein, and cellular localization correlates with apoptotic cell death, Exp Neurol, 166, 213, 10.1006/exnr.2000.7523 Cone, 1983, Regional distribution of dynorphin and neo-endorphin peptides in rat brain, spinal cord, and pituitary, J Neurosci, 3, 2146, 10.1523/JNEUROSCI.03-11-02146.1983 Evans, 1988, The opioid peptides, 23 Faden, 1988, Role of thyrotropin-releasing hormone and opiate receptor antagonists in limiting central nervous system injury, Adv Neurol, 47, 531 Faden, 1990, Opioid and non-opioid mechanisms may contribute to dynorphin’s pathophysiological actions in spinal cord injury, Ann Neurol, 27, 67, 10.1002/ana.410270111 Faden, 1992, Dynorphin increases extracellular levels of excitatory amino acids in the brain through a non-opioid mechanism, J Neurosci, 12, 425, 10.1523/JNEUROSCI.12-02-00425.1992 Faden, 1996, Neurotoxic versus neuroprotective actions of endogenous opioid peptides: implications for treatment of CNS injury, NIDA Res Monogr, 163, 318 Faden, 1984, Dynorphin-related peptides cause motor dysfunction in the rat through a non-opiate action, Br J Pharmacol, 81, 271, 10.1111/j.1476-5381.1984.tb10074.x Faden, 1985, Endogenous opioid immunoreactivity in rat spinal cord following traumatic injury, Ann Neurol, 17, 386, 10.1002/ana.410170414 Faden, 1987, Kappa-selective opiate antagonist nor-binaltorphimine improves outcome after traumatic spinal cord injury in rats, Cent Nerv Syst Trauma, 4, 227, 10.1089/cns.1987.4.227 Feldblum, 2000, Efficacy of a new neuroprotective agent, gacyclidine, in a model of rat spinal cord injury, J Neurotrauma, 17, 1079, 10.1089/neu.2000.17.1079 Garrido, 2004, Life’s smile, death’s grin: vital functions of apoptosis-executing proteins, Curr Opin Cell Biol, 16, 639, 10.1016/j.ceb.2004.09.008 Gentile, 1993, Antagonists of excitatory amino acids and endogenous opioid peptides in the treatment of experimental central nervous system injury, Ann Emerg Med, 22, 1028, 10.1016/S0196-0644(05)82746-5 Goody, 2003, Dynorphin A toxicity in striatal neurons via an α-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor mechanism, Neuroscience, 116, 807, 10.1016/S0306-4522(02)00563-8 Hauser, 2005, Pathobiology of dynorphins in trauma and disease, Front Biosci, 10, 216, 10.2741/1522 Hauser, 1999, Dynorphin A (1-13) neurotoxicity in vitro: opioid and non-opioid mechanisms in mouse spinal cord neurons, Exp Neurol, 160, 361, 10.1006/exnr.1999.7235 Hauser, 2001, Structure-activity analysis of dynorphin A toxicity in spinal cord neurons: Intrinsic neurotoxicity of dynorphin A and its carboxyl-terminal, non-opioid metabolites, Exp Neurol, 168, 78, 10.1006/exnr.2000.7580 Headrick, 1995, Intrathecal dynorphin-A infusion in rat spinal cord causes energy depletion, edema and neurologic dysfunction, Neurochem Int, 26, 489, 10.1016/0197-0186(94)00153-L Healy, 1994, Prodynorphin-derived peptide expression in primate cortex and striatum, Neuropeptides, 27, 277, 10.1016/0143-4179(94)90108-2 Hu, 1996, Dynorphin neurotoxicity induced nitric oxide synthase expression in ventral horn cells of rat spinal cord, Neurosci Lett, 203, 13, 10.1016/0304-3940(95)12246-X Jarskog, 2007, Caspase-3 activation in rat frontal cortex following treatment with typical and atypical antipsychotics, Neuropsychopharmacology, 32, 95, 10.1038/sj.npp.1301074 Knapp, 2001, Opiate signaling in oligodendrocytes: Possible autocrine effects on cell survival and development, Glia, 35, 156, 10.1002/glia.1080 Kolaj, 1995, The opioid peptide dynorphin modulates AMPA and kainate responses in acutely isolated neurons from the dorsal horn, Brain Res, 671, 227, 10.1016/0006-8993(94)01333-D Launay, 2005, Vital functions for lethal caspases, Oncogene, 24, 5137, 10.1038/sj.onc.1208524 Leuchtmann, 2003, AMPA receptors are the major mediators of excitotoxic death in mature oligodendrocytes, Neurobiol Dis, 14, 336, 10.1016/j.nbd.2003.07.004 Long, 1986, Endogenous opioids in spinal cord injury: a critical evaluation, Cent Nerv Syst Trauma, 3, 295, 10.1089/cns.1986.3.295 Long, 1994, Dynorphin A-induced rat spinal cord injury: evidence for excitatory amino acid involvement in a pharmacological model of ischemic spinal cord injury, J Pharmacol Exp Ther, 269, 358 Long, 2005, Inhibition of glutamate carboxypeptidase II (NAALADase) protects against dynorphin A-induced ischemic spinal cord injury in rats, Eur J Pharmacol, 508, 115, 10.1016/j.ejphar.2004.12.008 Massardier, 1989, A direct non-opiate interaction of dynorphin-(1–13) with the N-methyl-D-aspartate (NMDA) receptor, Eur J Pharmacol, 170, 125, 10.1016/0014-2999(89)90149-0 McAdoo, 1999, Changes in amino acid concentrations over time and space around an impact injury and their diffusion through the rat spinal cord, Exp Neurol, 159, 538, 10.1006/exnr.1999.7166 McDonald, 1998, Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor-mediated excitotoxicity, Nat Med, 4, 291, 10.1038/nm0398-291 McEwen, 2005, A mapping study of caspase-3 activation following acute spinal cord contusion in rats, J Histochem Cytochem, 53, 809, 10.1369/jhc.4A6467.2005 McIntosh, 1994, Central and systemic kappa-opioid agonists exacerbate neurobehavioral response to brain injury in rats, Am J Physiol, 267, R665 McIntosh, 1987, Endogenous opioids may mediate secondary damage after experimental brain injury, Am J Physiol, 253, E565 Merg, 2006, Big dynorphin as a putative endogenous ligand for the kappa-opioid receptor, J Neurochem, 97, 292, 10.1111/j.1471-4159.2006.03732.x Micu, 2006, NMDA receptors mediate calcium accumulation in myelin during chemical ischaemia, Nature, 439, 988, 10.1038/nature04474 Mu, 2002, NBQX treatment improves mitochondrial function and reduces oxidative events after spinal cord injury, J Neurotrauma, 19, 917, 10.1089/089771502320317078 Nottingham, 2002, FK506 treatment inhibits caspase-3 activation and promotes oligodendroglial survival following traumatic spinal cord injury, Exp Neurol, 177, 242, 10.1006/exnr.2002.7975 Nottingham, 2003, Temporal and spatial distribution of activated caspase-3 after subdural kainic acid infusions in rat spinal cord, J Comp Neurol, 464, 463, 10.1002/cne.10806 Nyberg, 1985, Identification of high molecular weight enkephalin precursor forms in human cerebrospinal fluid, Neuropeptides, 5, 537, 10.1016/0143-4179(85)90073-3 Oomman, 2006, Bergmann glia utilize active caspase-3 for differentiation, Brain Res, 1078, 19, 10.1016/j.brainres.2006.01.041 Oomman, 2005, Non-lethal active caspase-3 expression in Bergmann glia of postnatal rat cerebellum, Brain Res Dev Brain Res, 160, 130, 10.1016/j.devbrainres.2005.07.010 Park, 2004, The role of excitotoxicity in secondary mechanisms of spinal cord injury: a review with an emphasis on the implications for white matter degeneration, J Neurotrauma, 21, 754, 10.1089/0897715041269641 Ploj, 1999, Neonatal handling in rats induces long-term effects on dynorphin peptides, Neuropeptides, 33, 468, 10.1054/npep.1999.0764 Przewlocki, 1988, Prodynorphin gene expression in spinal cord is enhanced after traumatic injury in the rat, Brain Res, 464, 37, 10.1016/0169-328X(88)90016-2 Reed, 2003, Dynorphin A(1-17) biotransformation in striatum of freely moving rats using microdialysis and matrix-assisted laser desorption/ionization mass spectrometry, J Neurochem, 86, 815, 10.1046/j.1471-4159.2003.01859.x Salter, 2005, NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury, Nature, 438, 1167, 10.1038/nature04301 Sanchez-Gomez, 2003, Caspase-dependent and caspase-independent oligodendrocyte death mediated by AMPA and kainate receptors, J Neurosci, 23, 9519, 10.1523/JNEUROSCI.23-29-09519.2003 Sasek, 1984, The immunohistochemical localization of nine peptides in the sacral parasympathetic nucleus and the dorsal gray commissure in rat spinal cord, Neuroscience, 12, 855, 10.1016/0306-4522(84)90175-1 Scheff, 2003, Experimental modeling of spinal cord injury: characterization of a force-defined injury device, J Neurotrauma, 20, 179, 10.1089/08977150360547099 Sharifi, 2001, Generation of dynorphin knockout mice, Mol Brain Res, 86, 70, 10.1016/S0169-328X(00)00264-3 Shinoda, 1989, Brain region and gene specificity of neuropeptide gene expression in cultured astrocytes, Science, 245, 415, 10.1126/science.2569236 Shukla, 1997, Nonopioid motor effects of dynorphin A and related peptides: structure dependence and role of the N-methyl-D-aspartate receptor, J Pharmacol Exp Ther, 283, 604 Shuman, 1997, Apoptosis of microglia and oligodendrocytes after spinal cord contusion in rats, J Neurosci Res, 50, 798, 10.1002/(SICI)1097-4547(19971201)50:5<798::AID-JNR16>3.0.CO;2-Y Silberring, 1992, Dynorphin converting enzyme in the rat spinal cord, Life Sci, 50, 839, 10.1016/0024-3205(92)90202-Z Singh, 2003, Dynorphin A(1-17) induces apoptosis in striatal neurons in vitro through alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor-mediated cytochrome c release and caspase-3 activation, Neuroscience, 122, 1013, 10.1016/j.neuroscience.2003.08.033 Skilling, 1992, Selective potentiation of NMDA-induced activity and release of excitatory amino acids by dynorphin: possible roles in paralysis and neurotoxicity, Brain Res, 575, 272, 10.1016/0006-8993(92)90090-V Springer, 1999, Activation of the caspase-3 apoptotic cascade in traumatic spinal cord injury, Nat Med, 5, 943, 10.1038/11387 Sun, 2006, The expression of prodynorphin gene is down-regulated by activation with lipopolysaccharide in U-937 macrophage cells, J Neuroimmunol, 174, 52, 10.1016/j.jneuroim.2006.01.006 Sweetnam, 1986, Localization of dynorphin gene product-immunoreactivity in neurons from spinal cord and dorsal root ganglia, Neuroscience, 18, 947, 10.1016/0306-4522(86)90110-7 Tachibana, 1998, Dynorphin mRNA expression in dorsal horn neurons after traumatic spinal cord injury: temporal and spatial analysis using in situ hybridization, J Neurotrauma, 15, 485, 10.1089/neu.1998.15.485 Tan-No, 2001, Cytotoxic effects of dynorphins through nonopioid intracellular mechanisms, Exp Cell Res, 269, 54, 10.1006/excr.2001.5309 Tan-No, 1997, Levels of dynorphin peptides in the central nervous system and pituitary gland of the spontaneously hypertensive rat, Neurochem Int, 31, 27, 10.1016/S0197-0186(96)00137-4 Tang, 1999, High-affinity interaction of (des-Tyrosyl)dynorphin A(2-17) with NMDA receptors, J Pharmacol Exp Ther, 291, 760 Thornhill, 1989, Intrathecal dynorphin A administration causes pressor responses in rats associated with an increased resistance to spinal cord blood flow, Brain Res, 490, 174, 10.1016/0006-8993(89)90447-2 Vanderah, 1996, Single intrathecal injections of dynorphin A or des-Tyr-dynorphins produce long-lasting allodynia in rats: blockade by MK-801 but not naloxone, Pain, 68, 275, 10.1016/S0304-3959(96)03225-3 Vilijn, 1988, Expression of preproenkephalin mRNA in cultured astrocytes and neurons, Proc Natl Acad Sci U S A, 85, 6551, 10.1073/pnas.85.17.6551 Vink, 1990, Opiate antagonist nalmefene improves intracellular free Mg2+, bioenergetic state and neurologic outcome following traumatic brain injury in rats, J Neurosci, 10, 3524, 10.1523/JNEUROSCI.10-11-03524.1990 Walker, 1982, Nonopiate effects of dynorphin and des-Tyr-dynorphin, Science, 218, 1136, 10.1126/science.6128791 Winkler, 2002, Amino Acids, 23, 273, 10.1007/s00726-001-0138-y Woods, 2006, Decoy peptides that bind dynorphin noncovalently prevent NMDA receptor-mediated neurotoxicity, J Proteome Res, 5, 1017, 10.1021/pr060016+ Xu, 2005, Administration of glutamate into the spinal cord at extracellular concentrations reached post-injury causes functional impairments, Neurosci Lett, 384, 271, 10.1016/j.neulet.2005.04.100 Yakovlev, 1994, Sequential expression of c-fos protooncogene, TNF-alpha, and dynorphin genes in spinal cord following experimental traumatic injury, Mol Chem Neuropathol, 23, 179, 10.1007/BF02815410 Yang, 2004, Partial cleavage of RasGAP by caspases is required for cell survival in mild stress conditions, Mol Cell Biol, 24, 10425, 10.1128/MCB.24.23.10425-10436.2004 Yang, 2004, Surviving the kiss of death, Biochem Pharmacol, 68, 1027, 10.1016/j.bcp.2004.03.043 Yong, 1998, Apoptosis in cellular compartments of rat spinal cord after severe contusion injury, J Neurotrauma, 15, 459, 10.1089/neu.1998.15.459 Young, 1987, The degradation of dynorphin A in brain tissue in vivo and in vitro, Peptides, 8, 701, 10.1016/0196-9781(87)90046-5 Yum, 1990, Comparison of the neuroprotective effects of the N-methyl-D-aspartate antagonist MK-801 and the opiate-receptor antagonist nalmefene in experimental spinal cord ischemia, Arch Neurol, 47, 277, 10.1001/archneur.1990.00530030043014 Zipfel, 2000, Neuronal apoptosis after CNS injury: the roles of glutamate and calcium, J Neurotrauma, 17, 857, 10.1089/neu.2000.17.857